Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Covington
Citi
Chubb
Express Scripts
Johnson and Johnson
Julphar
Cerilliant
US Department of Justice

Generated: June 24, 2018

DrugPatentWatch Database Preview

TINDAMAX Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Tindamax, and when can generic versions of Tindamax launch?

Tindamax is a drug marketed by Mission Pharma and is included in one NDA.

The generic ingredient in TINDAMAX is tinidazole. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the tinidazole profile page.
Drug patent expirations by year for TINDAMAX
Pharmacology for TINDAMAX
Medical Subject Heading (MeSH) Categories for TINDAMAX
Synonyms for TINDAMAX
033KF7V46H
1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-nitro-1H-imidazole
1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-nitroimidazole
1-(2-Ethanesulfonyl-ethyl)-2-methyl-5-nitro-1H-imidazole
1-(2-ethylsulfonylethyl)-2-methyl-5-nitro-imidazole
1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazole
1-(2'-(ethylsulfonyl)-Ethyl]-2-Methyl-5-Nitroimidazole
1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane
1-[2-(2-Ethylsulfonyl)ethyl]-2-methyl-5-nitro-imidazole
1-[2-(ethanesulfonyl)ethyl]-2-methyl-5-nitro-1H-imidazole
1-[2-(Ethylsulfonyl)ethyl]-2-methyl-5-nitro-1H-imidazole
1-[2-(Ethylsulfonyl)ethyl]-2-methyl-5-nitroimidazole
1-[2'-(Ethylsulfonyl)-Ethyl]-2-Methyl-5-Nitroimidazole
19387-91-8
1H-Imidazole, 1-(2-(ethylsulfonyl)ethyl)-2-methyl-5-nitro-
1H-Imidazole, 1-[2-(ethylsulfonyl)ethyl]-2-methyl-5-nitro-
1H-Imidazole,1-[2-(ethylsulfonyl)ethyl]-2-methyl-5-nitro-
3B1-002676
4CH-017486
5-23-05-00067 (Beilstein Handbook Reference)
A813669
AB00053176
AB00053176_17
AB00053176_18
AB00053176-16
AB0012837
AB1009400
AC-1618
AC1L1KFT
AJ-11437
AK114670
AKOS000747070
Amtiba
AN-6513
BAS 00604596
BBL010767
BC203912
Bio-0521
Bioshik
BPBio1_000894
BRD-K89125793-001-05-4
BRN 0618182
BSPBio_000812
BSPBio_003183
C8H13N3O4S
CAS-19387-91-8
CCG-39907
CCRIS 7621
CHEBI:63627
CHEMBL1220
CP 12574
CP-12,574
CP-12574
CPD000058194
CS-2055
CTK4E1372
D01426
D0O4SE
DB00911
DivK1c_006804
DSSTox_CID_3676
DSSTox_GSID_23676
DSSTox_RID_77141
DTXSID4023676
EINECS 243-014-4
Ethyl (2-(2-methyl-5-nitro-1-imidazolyl)ethyl)sulfone
Fasigin
Fasigyn
Fasigyntrade mark
Fasygin
FT-0675241
Glongyn
Haisigyn (TN)
HE052719
HE322322
HJLSLZFTEKNLFI-UHFFFAOYSA-N
HMS1570I14
HMS1921L06
HMS2052C09
HMS2090B14
HMS2092D14
HMS2097I14
HMS2231E23
HMS3374P07
HMS3394C09
HMS3652A08
HSDB 7362
HY-B0177
I14-45143
Imidazole, 1-(2-(ethylsulfonyl)ethyl)-2-methyl-5-nitro-
K-5725
KB-212509
KBio1_001748
KBio2_001746
KBio2_004314
KBio2_006882
KBio3_002683
KBioGR_000899
KBioSS_001746
KS-00000J1U
KS-5180
LS-78715
MCULE-2580495783
MFCD00057217
MLS000069717
MLS001146883
MLS001424192
MolPort-000-810-622
MolPort-006-819-596
NC00346
NCGC00016741-01
NCGC00016741-02
NCGC00016741-03
NCGC00016741-04
NCGC00016741-05
NCGC00016741-06
NCGC00016741-07
NCGC00016741-09
NCGC00022212-03
NCGC00022212-04
NCGC00022212-05
NSC-758189
NSC758189
Opera_ID_779
Oprea1_342844
Pharmakon1600-01502127
Pletil
Prestwick_136
Prestwick0_000766
Prestwick1_000766
Prestwick2_000766
Prestwick3_000766
s4068
SAM001246913
SBB006917
SBI-0052674.P002
SCHEMBL21141
Simplotan
Simplotantrade mark
SMR000058194
Sorquetan
SPBio_000655
SPBio_002751
SpecPlus_000708
Spectrum_001266
SPECTRUM1502127
Spectrum2_000648
Spectrum3_001512
Spectrum4_000230
Spectrum5_001715
SR-01000000210
SR-01000000210-5
ST024770
ST2403077
STK801761
timidazole
Tindamax (TN)
Tindamaxtrade mark
Tinidazol
Tinidazol [INN-Spanish]
tinidazole
Tinidazole (JP17/USP/INN)
Tinidazole (oral), Mission Pharmacal
Tinidazole [USAN:BAN:INN:JAN]
Tinidazole [USAN:USP:INN:BAN:JAN]
Tinidazole, European Pharmacopoeia (EP) Reference Standard
Tinidazole, United States Pharmacopeia (USP) Reference Standard
Tinidazole, VETRANAL(TM), analytical standard
Tinidazolum
Tinidazolum [INN-Latin]
Tox21 110586
Tox21_110586
Tox21_110586_1
Tricolam
Trimonase
UNII-033KF7V46H
VU0239922-6
Z56763819
ZINC113446

US Patents and Regulatory Information for TINDAMAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mission Pharma TINDAMAX tinidazole TABLET;ORAL 021618-001 May 17, 2004 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mission Pharma TINDAMAX tinidazole TABLET;ORAL 021618-002 May 17, 2004 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Colorcon
Cantor Fitzgerald
Covington
Daiichi Sankyo
Chinese Patent Office
Johnson and Johnson
Harvard Business School
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.